Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

NeoGenomics Inc (NEO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow NeoGenomics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
13.53 -0.24    -1.74%
19/04 - Closed. Currency in USD ( Disclaimer )
After Hours
12.86
-0.67
-4.95%
19:18:55 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 726,025
  • Bid/Ask: 12.62 / 13.50
  • Day's Range: 13.42 - 13.78
NeoGenomics 13.53 -0.24 -1.74%

NeoGenomics Inc Company Profile

 
Get an in-depth profile of NeoGenomics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Providers & Services
SectorHealthcare
Employees

2100

Equity Type

ORD

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients’ oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.

Contact Information

Address 9490 NeoGenomics Way
Fort Myers, 33912
United States
Phone 239 768 0600
Fax 239 690 4237

Top Executives

Name Age Since Title
Lynn A. Tetrault 59 2015 Independent Chair of the Board
Christopher Michael Smith 60 2022 CEO & Director
Razelle Kurzrock - 2021 Member of Scientific Advisory Board
Michael A. Kelly 67 2020 Independent Director
Bernard A. Fox 70 2021 Member of Scientific Advisory Board
Alison L. Hannah 63 2015 Member of Scientific Advisory Board & Independent Director
Bruce K. Crowther 72 2014 Independent Director
James R. Downing - 2021 Member of Scientific Advisory Board
Stephen M. Kanovsky 61 2017 Independent Director
Riccardo Dalla-Favera 72 2021 Member of Scientific Advisory Board
Anthony P. Zook 63 2023 Independent Director
Mark A. Rubin - 2021 Member of Scientific Advisory Board
Rafael Bejar 51 2023 Member of Scientific Advisory Board
David Brian Perez 65 2022 Independent Director
Neil Gunn - 2023 Independent Director
Elizabeth Floegel - 2023 Independent Director
Tibor Kovacsovics - 2023 Scientific Advisory Board Member
Steven T. Rosen - 2021 Member of Scientific Advisory Board
James R. Berenson - 2023 Scientific Advisory Board Member
John N. Allan - 2023 Scientific Advisory Board Member
Gail J. Roboz - 2023 Scientific Advisory Board Member
Hatim Husain - 2024 Scientific Advisory Board Member
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NEO Comments

Write your thoughts about NeoGenomics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Edward Lee
Fibonacci6180 Apr 22, 2023 12:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Trading idea – Entry point has to be over 16.2/61.80%
Yurii Hidden
Azazavr Dec 28, 2021 4:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Time to buy. Right now @ 32.55
Rob Roo
Rob Roo Oct 22, 2021 3:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Power hour!!! 🚀🚀🚀🚀🚀🚀🚀💎
Rob Roo
Rob Roo Oct 15, 2021 3:21PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Power hour!!! 🚀🚀🚀🚀🚀🚀🚀💎
Lucas Whipps
Lucas Whipps Sep 09, 2021 12:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I'm still wearing a 20% hit so hoping for a trading to recoup some of the loss if the figures are better than expected. I've been faithful to Boo quite a while but want to release some funds for the SpectrumX pre-ipo. I need an investment without the drama!
Rob Roo
Rob Roo Jun 24, 2021 4:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
10 Bagger!!! 🚀🚀🚀🚀🚀🚀🚀
Ray Quinones
Ray Quinones Jan 27, 2021 9:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I bought this stock on accident thinking it was NIO does anyone expect growth from this stock or is it just a dud?
Robert Cencarik
Robert Cencarik Jan 27, 2021 9:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
you might just got really lucky...
Ray Quinones
Ray Quinones Jan 27, 2021 9:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I bought this stock on accident thinking it was NIO does anyone expect growth from this stock or is it just a dud?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email